Patents/Assignees

BETA PHARMA, Inc.

4 patents in portfolio

US12595246utility2026
Crystalline and Amorphous Forms of N-(5-((4-ethylpiperazin-1-yl)methyl)pyridine-2-yl)-5-fluoro-4-(3-isopropyl-2-methyl-2h-indazol-5-yl)pyrimidin-2-amine and Its Salts, and Preparation Methods and Therapeutic Uses Thereof
0 cites
US12390464utility2025
Treatment of EGFR Mutant-related Cancers Using a Combination of EGFR and CDK4/6 Inhibitors
0 cites
US12258365utility2025
Organophosphorus-substituted Compounds as C-met Inhibitors and Therapeutic Uses Thereof
0 cites
US12187707utility2025
Pharmaceutical Formulations of N -(2-(2-(dimethylamino)ethoxy)-4-methoxy-5-((4-(1-methyl-1h-indol-3-yl)pyrimidin-2-yl)amino)phenyl)acrylaminde and Salts Thereof
0 cites